However, both the DEX and ATA treatment did not affect the protein expression levels of cyclin A and cyclin E. Interestingly, upregulation of growth arrest regulatory proteins, p21Cip1 and p27Kip1, was also detected with either DEX or ATA treatment in breast cancer cells [79]. The gene discussed is CDKN1A; the disease is breast carcinoma.